Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Notebook: Remdesivir Supply Dwindles; US FDA Signs Another RWE Deal; Corning Gets BARDA Contract For Glass Vials

Covid19_Cell_Microscope

Related Content

Glass-Related Drug Recalls Decline After Industry Improves Practices

Feb 06 2018

Real-World Evidence Likely Untainted By COVID-19 Journal Article Debacle

Jun 09 2020

Gilead Licenses Remdesivir To Five Firms

May 13 2020

Trump Lauds Big Pharma Collaboration On Super Strong Glass Packaging

Jul 21 2017

Coronavirus Notebook: US FDA Cuts Hotline Hours, Regulatory Relief May Be Permanent, Trump's Hydroxychloroquine Prescription

May 20 2020

Trump’s ‘Warp Speed’ Initiative Could Fund 3 to 5 Large-Scale COVID Vaccine Trials

May 18 2020

Real-World Data Partnership On COVID-19: US FDA Drawn To Consistency, Diversity of Aetion's Datasets

May 22 2020

When A Sponsor Wants To Proceed On A COVID Product, US FDA Almost Never Says No

May 22 2020

How Gilead Intends To Deliver On Promise Of Remdesivir For COVID-19

May 08 2020

Senators Seek Answers On Remdesivir Allocation As FEMA Aims For Better Process Next Time

May 11 2020

Remdesivir Distribution Begins With More Questions Than Answers

May 08 2020

Gilead’s Second Chance To Re-Set The Drug Price Debate

May 07 2020

Big Gaps In Vaccination Supplies Highlighted In Whistleblower Complaint; Will RAPID Partnership Save The Day?

May 07 2020

Related Companies

Gilead Sciences, Inc.

Merck & Co., Inc.

Pfizer Inc.

BioNTech SE

Additional Topics

United States Coronavirus COVID-19 Real-World Evidence Advertising, Marketing & Sales Regulation BioPharmaceutical

More from Real-World Evidence

More from Clinical Trials

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window